SummaryBasal-like breast cancers (BLBCs) are aggressive, and their drivers are unclear. We have found that wild-type N-RAS is overexpressed in BLBCs but not in other breast cancer subtypes. Repressing N-RAS inhibits transformation and tumor growth, whereas overexpression enhances these processes even in preinvasive BLBC cells. We identified N-Ras-responsive genes, most of which encode chemokines; e.g., IL8. Expression levels of these chemokines and N-RAS in tumors correlate with outcome. N-Ras, but not K-Ras, induces IL-8 by binding and activating the cytoplasmic pool of JAK2; IL-8 then acts on both the cancer cells and stromal fibroblasts. Thus, BLBC progression is promoted by increasing activities of wild-type N-Ras, which mediates autocr...
SummaryMutations in KRAS are prevalent in human cancers and universally predictive of resistance to ...
Oncogenic activation of Ras proteins due to missense mutations is frequently detected in human cance...
Mutations in KRAS are prevalent in human cancers and universally predictive of resistance to antican...
Basal-like breast cancers (BLBCs) are aggressive, and their drivers are unclear. We have found that ...
SummaryBasal-like breast cancers (BLBCs) are aggressive, and their drivers are unclear. We have foun...
INTRODUCTION. The Ras/Raf//MAPK pathway regulates multiple cellular processes such as proliferation,...
<p>The Ras family of proteins, composed of H, N, and KRas, function as small GTPases that act as "mo...
ABSTRACT N-RAS is one member of a family of oncoproteins that are commonly mutated in cancer. Activa...
AbstractThe role of Ras oncogenes in promoting cellular transformation is well established. However,...
Oncogenic activation of RAS isoforms leads tumor initiation and progression in many types of cancers...
<p>The RAS family is a group of small GTPases that can become constitutively activated by point muta...
Mutationally activated RAS proteins are critical oncogenic drivers in nearly 30% of all human cancer...
We previously reported that oncogenic KRAS activation of the PI3K/AKT pathway stimulates the remaini...
We previously reported that oncogenic KRAS activation of the PI3K/AKT pathway stimulates the remaini...
SummaryRAS genes are commonly mutated in cancer; however, RAS mutations are rare in breast cancer, d...
SummaryMutations in KRAS are prevalent in human cancers and universally predictive of resistance to ...
Oncogenic activation of Ras proteins due to missense mutations is frequently detected in human cance...
Mutations in KRAS are prevalent in human cancers and universally predictive of resistance to antican...
Basal-like breast cancers (BLBCs) are aggressive, and their drivers are unclear. We have found that ...
SummaryBasal-like breast cancers (BLBCs) are aggressive, and their drivers are unclear. We have foun...
INTRODUCTION. The Ras/Raf//MAPK pathway regulates multiple cellular processes such as proliferation,...
<p>The Ras family of proteins, composed of H, N, and KRas, function as small GTPases that act as "mo...
ABSTRACT N-RAS is one member of a family of oncoproteins that are commonly mutated in cancer. Activa...
AbstractThe role of Ras oncogenes in promoting cellular transformation is well established. However,...
Oncogenic activation of RAS isoforms leads tumor initiation and progression in many types of cancers...
<p>The RAS family is a group of small GTPases that can become constitutively activated by point muta...
Mutationally activated RAS proteins are critical oncogenic drivers in nearly 30% of all human cancer...
We previously reported that oncogenic KRAS activation of the PI3K/AKT pathway stimulates the remaini...
We previously reported that oncogenic KRAS activation of the PI3K/AKT pathway stimulates the remaini...
SummaryRAS genes are commonly mutated in cancer; however, RAS mutations are rare in breast cancer, d...
SummaryMutations in KRAS are prevalent in human cancers and universally predictive of resistance to ...
Oncogenic activation of Ras proteins due to missense mutations is frequently detected in human cance...
Mutations in KRAS are prevalent in human cancers and universally predictive of resistance to antican...